These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26643062)

  • 21. Community-onset extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 at two Korean community hospitals: The spread of multidrug-resistant E. coli to the community via healthcare facilities.
    Kim YA; Kim JJ; Kim H; Lee K
    Int J Infect Dis; 2017 Jan; 54():39-42. PubMed ID: 27865830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital.
    Tóth K; Tóth Á; Kamotsay K; Németh V; Szabó D
    Ann Clin Microbiol Antimicrob; 2022 Feb; 21(1):3. PubMed ID: 35144632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China.
    Zhang F; Zhu D; Xie L; Guo X; Ni Y; Sun J
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1263-9. PubMed ID: 25759112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
    Demirci-Duarte S; Unalan-Altintop T; Eser OK; Cakar A; Altun B; Sancak B; Gur D
    Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115098. PubMed ID: 32603974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolone Resistance Mechanisms by Molecular Epidemiologic Study of Ciprofloxacin-Nonsusceptible
    Yang HS; Kim Y; Cho SY; Nam YS; Oh TS; Park KS; Kim HC; Lee HJ
    Ann Clin Lab Sci; 2017 Aug; 47(4):511-515. PubMed ID: 28801381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of Escherichia coli sequence type 131 among antimicrobial-resistant E. coli isolates from geriatric patients.
    Ho PL; Chu YP; Lo WU; Chow KH; Law PY; Tse CW; Ng TK; Cheng VC; Que TL
    J Med Microbiol; 2015 Mar; 64(Pt 3):243-247. PubMed ID: 25587081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras P; Johnson JR
    PLoS One; 2018; 13(7):e0200442. PubMed ID: 29990385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.
    Merino I; Hernández-García M; Turrientes MC; Pérez-Viso B; López-Fresneña N; Diaz-Agero C; Maechler F; Fankhauser-Rodriguez C; Kola A; Schrenzel J; Harbarth S; Bonten M; Gastmeier P; Canton R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2018 Nov; 73(11):2973-2980. PubMed ID: 30124851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6')Ib-cr Among Ciprofloxacin-Resistant
    Alsharapy SA; Yanat B; Lopez-Cerero L; Nasher SS; Díaz-De-Alba P; Pascual Á; Rodríguez-Martínez JM; Touati A
    Microb Drug Resist; 2018 Dec; 24(10):1537-1542. PubMed ID: 29883247
    [No Abstract]   [Full Text] [Related]  

  • 31. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR; Johnston B; Clabots C; Kuskowski MA; Castanheira M
    Clin Infect Dis; 2010 Aug; 51(3):286-94. PubMed ID: 20572763
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Hastak P; Fourment M; Darling AE; Gottlieb T; Cheong E; Merlino J; Myers GSA; Djordjevic SP; Roy Chowdhury P
    Emerg Microbes Infect; 2020 Dec; 9(1):1780-1792. PubMed ID: 32686595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.
    Dhanji H; Doumith M; Rooney PJ; O'Leary MC; Loughrey AC; Hope R; Woodford N; Livermore DM
    J Antimicrob Chemother; 2011 Feb; 66(2):297-303. PubMed ID: 21131323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.
    Peirano G; van der Bij AK; Freeman JL; Poirel L; Nordmann P; Costello M; Tchesnokova VL; Pitout JD
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3762-7. PubMed ID: 24752265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of ESBL-Producing
    Zendri F; Maciuca IE; Moon S; Jones PH; Wattret A; Jenkins R; Baxter A; Timofte D
    Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.
    Olesen B; Frimodt-Møller J; Leihof RF; Struve C; Johnston B; Hansen DS; Scheutz F; Krogfelt KA; Kuskowski MA; Clabots C; Johnson JR
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6886-95. PubMed ID: 25199783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.